New website forecasts turbulence risk for nervous flyers
The site uses data from NOAA and the Met Office to monitor and forecast turbulence, presenting it in an hour-by-hour graph indicating light, moderate, or strong turbulence.
Turbli.com also provides interactive turbulence maps, tailwind/headwind predictions, crosswind data, and thunderstorm forecasts.
In North America, Denver, Colorado, is identified as the most turbulent airport for approaches and descents, while Albuquerque to Denver is the most turbulent route.
Turbulence is caused by warm air rising, mountains disrupting airflow, and pockets of air moving in different directions, but modern aircraft are designed to withstand it, and serious injuries are rare, according to FAA data.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
24 minutes ago
- The Independent
Spirit Airlines warns it could soon go out of business as Americans shy away from trips
Spirit Airlines warned Monday that despite emerging from bankruptcy and pursuing new revenue streams, it may not be able to stay in business over the next year. Just five months after emerging from Chapter 11 bankruptcy, its parent company, Spirit Aviation Holdings, says there is "substantial doubt" about the airline's ability to continue operating over the next year, according to its quarterly report published Monday. Despite efforts to restructure debt and secure new financing following its exit from bankruptcy in March, the airline faces continued challenges. Weak demand for domestic leisure travel and enduring operational uncertainties are among the critical pressures prompting the warning. By early Tuesday afternoon, Spirit's stock had plunged nearly 40 percent, trading at just above $2.20. The airline said it expects to continue 'for at least the remainder of 2025.' Famous for its no-frills, ultra-low-cost flights aboard bright yellow jets, Spirit has faced ongoing challenges regaining its footing and staying competitive since the COVID-19 pandemic. Escalating operating expenses and growing debt pushed the carrier to file for bankruptcy protection in November 2024, after racking up more than $2.5 billion in losses since early 2020. Spirit became the first major US airline to file for Chapter 11 bankruptcy since American Airlines did so in 2011. Spirit has implemented cost-saving measures, including furloughing 270 pilots and demoting 140 captains, with changes scheduled for October 1 and November 1 to align with anticipated flight volumes in 2026. The airline also plans to sell aircraft and real estate to generate much-needed cash. Spirit is also shifting strategy and rolling out tiered pricing with added amenities, aiming to appeal to higher-paying travelers and diversify beyond its traditional ultra-low-fare base. Previous talks of mergers or takeovers, by JetBlue or Frontier, have stalled, and Spirit has signaled no renewed interest in such moves since restructuring.
Daily Mail
an hour ago
- Daily Mail
Vaccine on RFK Jr's chopping block could protect against one of the deadliest cancers
Experimental mRNA vaccines shrouded in controversy may protect against one of America's deadliest cancers, a new study suggests. Researchers across the country tested a personalized mRNA vaccine on people with pancreatic cancer who had already had surgery and still had traces of the disease remaining. Pancreatic cancer is one of the hardest forms of the disease to treat, with a five-year survival rate of just 12 percent. And most cases are diagnosed after the disease has ravaged other organs, as it symptoms are usually mistaken for more benign issues. The vaccine uses mRNA technology, which uses RNA to tell cells how to make proteins and induce an immune reaction, to targets mutations of the KRAS gene. KRAS mutations are thought to be responsible for nine in 10 pancreatic cancers and nearly half of colon cancers. The researchers, from major institutions like Memorial Sloan Kettering Cancer Center in New York City and the University of California, Los Angeles (UCLA), found about 85 percent of participants had an immune response to the vaccine. And two-thirds had enough of a response to stave off lingering cancer cells. Participants also lived more than twice as long after getting the vaccine than pancreatic cancer patients on average. Dr Zev Wainberg, trial leader and co-director of the UCLA gastrointestinal oncology program, told NBC News: 'That far exceeds the rates with resectable cancers.' Resectable cancers are those than can be removed with surgery. mRNA technology, which is also used in Covid vaccines, has been hailed a 'game-changer' in the cancer space, leading to a mountain of new trials testing if it can be used in vaccines. In one research paper out of Penn State College of Medicine, the scientists note: 'mRNA vaccines are an attractive and powerful immunotherapeutic platform against cancer because of their high potency, specificity, versatility, rapid and large-scale development capability, low-cost manufacturing potential, and safety.' Despite expert consensus and scientific evidence, however, Health Secretary Robert F Kennedy Jr, a longtime vaccine skeptic, has repeatedly cast doubt on the safety and efficacy of mRNA vaccines. Earlier this month he announced the Department of Health and Human Services (HHS) would cancel nearly $500million in contracts for new vaccine development, including those for mRNA shots. Pancreatic cancer affects roughly 67,000 Americans every year and kills about 52,000. Along with colon cancer, it is also increasingly affecting young people. More than half the time, the disease is first spotted after it has already reached stage three or four due to its vague symptoms. These include abdominal pain, weight loss, back pain, jaundice and floating or clay-colored stools. This leads patients to assume their symptoms are from more benign causes like irritable bowel syndrome (IBS). By the time it reaches stage four, the five-year survival rate is just three percent, making it virtually incurable. It's unclear exactly what causes pancreatic cancer, but smoking, obesity and diabetes are thought to increase the risk by inducing harmful inflammation that causes cells to divide and become mutated more easily. In the new phase I trial, published Monday in the journal Nature Medicine, doctors recruited 20 people with pancreatic cancer and five with colorectal cancer. All participants had a KRAS mutation and had undergone standard treatment, which usually includes chemotherapy and surgery, to shrink and remove most of their tumors. Blood tests revealed the patients had traces of cells left behind, known as microscopic residual disease, which can travel elsewhere in the body and grow into tumors. After surgery, each participant received up to six doses of the vaccine, called ELI-002 2P, and 13 also received booster shots. The team found 85 percent, or 21 out of 25 participants, showed an immune response to the vaccine, and about 66 percent had enough of an immune response to stave off lingering cancer cells. And in nearly 70 percent of participants, the vaccine triggered an immune response not just to KRAS mutations but to other tumor cell targets not in the vaccine. The phase 1 trial also showed people with pancreatic cancer survived for an average of 29 months and lived recurrence-free for 15 months. The average survival length for patients with stage four pancreatic cancer, which is when most are diagnosed, is usually just six months to a year. The team is now running a phase 2 trial to test the vaccine's durability and compare if it is more effective than the current standard of care, which involves monitoring for disease recurrence.
The Guardian
an hour ago
- The Guardian
Canadians steer clear of US as travel from north falls for seventh month
Travel to the US by Canadian residents has continued to drop significantly for the seventh month in a row, as new data confirms that Donald Trump's threats have helped upend the summer tourism season. Months of aggressive rhetoric from the White House have prompted widespread boycotts of US products by Canadians, who have also sworn off visits to their southern neighbour amid lingering feelings of betrayal and anger. Statistics Canada said on Monday that the number of Canadian residents who made a return trip to the US by car dropped 36.9% in July 2025, compared with the same month in 2024. There were declines in air travel as well, where Canadian residents returning from the US by commercial airlines dropped by 25.8% in July compared with the previous year. Those figures have been broadly attributed to fury over Trump's antagonistic trade policies and threats to annex Canada, but they have also been fed by the country's persistent cost of living crisis, said Isabelle Salle, an associate professor of behavioral macroeconomics at the University of Ottawa. 'There is a growing disconnect between the economy in Canada and the state of the economy in the US,' she said. The Canadian dollar is faring poorly compared with the greenback and many Canadian families are feeling squeezed by persistently high housing costs and wages which are lagging behind inflation, said Salle. 'People have directly lost in terms of purchasing power,' Salle said. The uncertainty of the trade war and fears about future job losses are keeping people from spending money on leisure now just in case, she added. Meanwhile, US residents' travel to Canada by land declined by 7.4% in July compared with the same month in 2024, but visits by air increased very slightly by 0.7%, amounting to 714,700 US residents. 'When they have some green signals [in the US economy], our lights are rather red,' said Salle. 'The broad picture does not show two economies that are coordinated in the same direction.'
